Evidence map›Paper›PMID 21163293›Full record

ReviewFrontiers in neuroendocrinology2011

Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.

Anne M Etgen, Teresa Jover-Mengual, R Suzanne Zukin

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CBJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  9. Article
  10. GPER modulators: Opportunity Nox on the heels of a class Akt.The Journal of steroid biochemistry and molecular biology · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. What have we learned about GPER function in physiology and disease from knockout mice?The Journal of steroid biochemistry and molecular biology · 2015
    Review
  15. Review
  16. Review
  17. Non-feminizing estrogens: a novel neuroprotective therapy.Molecular and cellular endocrinology · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Anne M EtgenDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. anne.etgen@einstein.yu.edu
Teresa Jover-Mengual
R Suzanne Zukin
Albert Einstein College of Medicine · USUniversitat de València · ES

Funding

Estrogen: Neuroprotection and RescueR01NS045693 · NINDS · YESHIVA UNIVERSITY · PI ZUKIN, R. SUZANNE · 2003 to 2014
$4.2M
STEROID HORMONES--BRAIN &BEHAVIORR37MH041414 · NIMH · YESHIVA UNIVERSITY · PI ETGEN, ANNE M · 1988 to 2007
$3.3M
Estrogen: Neuroprotection in the PerimenopauseR01AG027702 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ETGEN, ANNE M · 2006 to 2010
$2.0M
STEROID HORMONE--BRAIN AND BEHAVIORR01MH041414 · NIMH · YESHIVA UNIVERSITY · PI ETGEN, ANNE M · 1985 to 1987
–
NIA NIH HHS R01 AG027702NIMH NIH HHS R01 MH41414NIMH NIH HHS R37 MH041414NINDS NIH HHS R01 NS045693
6 · The paper itself

Abstract

This review highlights our investigations into the neuroprotective efficacy of estradiol and other estrogenic agents in a clinically relevant animal model of transient global ischemia, which causes selective, delayed death of hippocampal CA1 neurons and associated cognitive deficits. We find that estradiol rescues a significant number of CA1 pyramidal neurons that would otherwise die in response to global ischemia, and this is true when hormone is provided as a long-term pretreatment at physiological doses or as an acute treatment at the time of reperfusion. In addition to enhancing neuronal survival, both forms of estradiol treatment induce measurable cognitive benefit in young animals. Moreover, estradiol and estrogen analogs that do not bind classical nuclear estrogen receptors retain their neuroprotective efficacy in middle-aged females deprived of ovarian hormones for a prolonged duration (8weeks). Thus, non-feminizing estrogens may represent a new therapeutic approach for treating the neuronal damage associated with global ischemia.

Indexed as

AnimalsEstradiolEstradiol CongenersHumansIschemiaNeuroprotective AgentsEstradiolEstradiol CongenersNeuroprotective Agents

Identifiers

PMID21163293
PMCPMC3080451
OpenAlexW2074568782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.